Current status and prospects for some improved and new bacterial vaccines.
D016667:Bacterial Capsules; D001428:Bacterial Vaccines / Q000276:immunology; D003428:Cross Infection / Q000517:prevention & control; D004168:Diphtheria Toxoid / Q000276:immunology; D006192:Haemophilus Infections / Q000517:prevention & control; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D008589:Meningococcal Infections / Q000517:prevention & control; D022401:Meningococcal Vaccines; D010567:Pertussis Vaccine / Q000009:adverse effects / Q000276:immunology; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines; D011135:Polysaccharides, Bacterial / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000276:immunology; D013745:Tetanus Toxoid / Q000276:immunology; D014481:United States; D014613:Vaccines, Attenuated / Q000276:immunology; D014917:Whooping Cough / Q000517:prevention & control
D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D022401:Meningococcal Vaccines; D010567:Pertussis Vaccine; D022242:Pneumococcal Vaccines; D011135:Polysaccharides, Bacterial; D013745:Tetanus Toxoid; D014613:Vaccines, Attenuated